1 active not recruiting, 1 completed, 1 unknown. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Completed 1 |
Follow Atypical Squamous Cells of Undetermined Significance: new trials by email Literature Review of Atypical Squamous Cells of Undetermined Significance trials Research Report on Atypical Squamous Cells of Undetermined Significance
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Primary Cervical Cancer Screening by Self-sampling HPV Test Human Papillomavirus Infection, Cervical Cancer | Active not recruiting | Peking University People's Hospital | 17875 | 2022-11-19 | 2023-12-21 | |
| Clinical Evaluation of Detection of High Risk HPV in Urine Human Papillomavirus Infection, Cervical Cancer | Unknown | Peking University People's Hospital | 1000 | 2021-09-15 | 2022-01-27 | |
| SGN-00101 Vaccine in Treating Human Papillomavirus in Patients Who Have Abnormal Cervical Cells HspE7, placebo, laboratory biomarker analysis - Atypical Squamous Cells of Undetermined Significance, Cervical Cancer | Phase 2 | Completed | National Cancer Institute (NCI) | 139 | 2004-09-01 | 2013-06-03 |
Atypical Squamous Cells of the Cervix (3) · Squamous Intraepithelial Lesions (3) · Uterine Cervical Neoplasms (3) · Adenocarcinoma in Situ (2) · Papillomavirus Infections (2) · Uterine Cervical Dysplasia (2) · Neoplasms (1)
Female Urogenital Diseases (3) · Female Urogenital Diseases and Pregnancy Complications (3) · Genital Diseases (3) · Genital Diseases, Female (3) · Genital Neoplasms, Female (3) · Morphological and Microscopic Findings (3) · Neoplasms by Site (3) · Pathological Conditions, Signs and Symptoms (3) · Precancerous Conditions (3) · Urogenital Diseases (3) · Urogenital Neoplasms (3) · Uterine Cervical Diseases (3) · Uterine Diseases (3) · Uterine Neoplasms (3) · Adenocarcinoma (2)
Peking University People's Hospital (2) · National Cancer Institute (NCI) (1)
China (2) · United States (1)
Frank Meyskens (1)